Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...

Traditional drug discovery often screens vast chemical libraries, a process that is costly, slow, and prone to producing molecules that hit multiple targets. By starting with tiny molecular fragments ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.